PAR 0.00% 19.5¢ paradigm biopharmaceuticals limited..

Chart, page-1212

  1. 1,750 Posts.
    lightbulb Created with Sketch. 1902
    Recruiting for the Phase III OA trial is expected to begin in January, and hoped to conclude by end of June. One of the analysts, I think Bell Potter, felt this was optimistic in this environment and that it might take longer....potentially pushing trial start - and therefore trial finish and readout - out by a few months.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.